DaVita Inc. (NYSE:DVA) Shares Bought by Sei Investments Co.

Sei Investments Co. increased its holdings in DaVita Inc. (NYSE:DVA) by 212.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,769 shares of the company’s stock after acquiring an additional 61,731 shares during the quarter. Sei Investments Co. owned approximately 0.11% of DaVita worth $13,578,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Thrivent Financial for Lutherans raised its holdings in shares of DaVita by 49.4% in the third quarter. Thrivent Financial for Lutherans now owns 8,131 shares of the company’s stock valued at $1,333,000 after buying an additional 2,688 shares during the last quarter. Raymond James Trust N.A. purchased a new stake in DaVita during the 3rd quarter valued at approximately $223,000. Cerity Partners LLC lifted its position in DaVita by 26.9% during the 3rd quarter. Cerity Partners LLC now owns 19,644 shares of the company’s stock worth $3,220,000 after acquiring an additional 4,165 shares during the period. Daiwa Securities Group Inc. grew its stake in shares of DaVita by 6.0% in the 3rd quarter. Daiwa Securities Group Inc. now owns 6,187 shares of the company’s stock valued at $1,014,000 after purchasing an additional 348 shares during the last quarter. Finally, Bank of Montreal Can increased its holdings in shares of DaVita by 0.9% in the third quarter. Bank of Montreal Can now owns 60,929 shares of the company’s stock valued at $9,936,000 after purchasing an additional 520 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

DVA stock opened at $150.29 on Friday. The company has a market cap of $12.02 billion, a price-to-earnings ratio of 13.99, a PEG ratio of 1.07 and a beta of 0.99. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a 50 day moving average of $157.39 and a 200-day moving average of $157.50. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on DVA shares. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. StockNews.com downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research report on Friday, March 21st. Finally, Barclays lifted their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.